Rights and permissions
About this article
Cite this article
Should second-line agents be continued long term in RA?. Inpharma Wkly. 1024, 17 (1996). https://doi.org/10.2165/00128413-199610240-00042
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199610240-00042